EPC

Edgewell Personal CareF

NYSE / Household & Personal Products

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$21.00

+12.5% vs current

Most likely

Base case

45%

Probability

Target price

$16.50

-11.6% vs current

B-

Bear case

30%

Probability

Target price

$12.50

-33.0% vs current

AI sentiment snapshot

Latest data as of 2026-05-16

AI commentary

Primary-source evidence is solid, but the forward view is still mixed: Q2 beat management’s expectations and adjusted guidance was reaffirmed, yet organic growth and margin trends remain weak enough that the thesis still looks like a restructuring-and-execution monitor rather than a clean re-rating story. Newsflow is light, analyst-coverage depth is unclear, and the May 15, 2026 anchor price of $15.93 versus the packet’s $24.33 median target suggests the market is still discounting execution risk.

RankAlpha Sentiment Codex - 2026-05-16

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-08-14catalystNext quarterly print must validate the reaffirmed adjusted outlookHigh impact

Q2 sales, adjusted EPS and EBITDA were ahead of management expectations, but organic net sales still fell 2.4% and North America organic sales fell 4.8%; the next report is the clearest test of whether execution, innovation and U.S. commercial actions can move the business back toward organic growth while protecting margin [#8-K-2026-05-06].

2026-09-30eventRestructuring and supply-chain consolidation need to translate into margin reliefHigh impact

Management raised expected fiscal 2026 pre-tax restructuring charges to about $90 million, while the 10-Q shows Mexico facility consolidation targeted for completion by Q4 fiscal 2026 and further North America Wet Shave consolidation extending to Q4 fiscal 2028; investors need evidence that these actions improve the gross-margin bridge rather than just add near-term cost [#10-Q-2026-05-06] [#8-K-2026-05-06].

2027-05-01catalystPost-divestiture portfolio simplification can support a cleaner cash-flow story if core brands sustain momentumHigh impact

After selling Feminine Care, Edgewell is emphasizing international growth, innovation, productivity and U.S. commercial transformation, with management citing momentum in Cremo, Hawaiian Tropic and Billie; the long case depends on those brands offsetting Wet Shave and Sun Care volatility and converting into better cash flow and lower leverage over the next several quarters [#8-K-2026-05-06] [#10-Q-2026-05-06].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-16 • Updated nightlySource: Internal modelMethodology